Literature DB >> 22124100

BEAM trial: lighting the way ahead?

Adil I Daud.   

Abstract

Mesh：

Year:  2011        PMID： 22124100     DOI： 10.1200/JCO.2011.37.5832

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  In vitro and in ovo experimental study of two anti-VEGF agents used in ophthalmology.

Authors:  Mădălina Casiana Palfi; Ovidiu Muşat; Edward Paul Şeclăman; Mihnea Munteanu; Adina Iuliana Milcu; Andreea Iordache; Alina Dolghi; Sînziana Luminiţa Istrate; Ileana Ramona Barac; Veronica Mădălina Borugă
Journal:  Rom J Morphol Embryol       Date:  2021 Jul-Sep       Impact factor: 0.833

Review 2.  Abiraterone acetate: targeting persistent androgen dependence in castration-resistant prostate cancer.

Authors:  Lauren C Harshman; Mary-Ellen Taplin
Journal:  Adv Ther       Date:  2013-08-27       Impact factor: 3.845
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.